A-View

A-View | Stroke2prevent | Transoesophageal Echocardiography | Modified TEE | Medical Device | Cardiothoracic surgery | Cardiothoracic Anaesthesiology |

[A-View @stroke2prevent]

The date is approaching: Oct. 17, 2022. VIZIENT will announce the winner of the prestigious annual Innovative Technology Exchange in Dallas. The A-View safety device enables TEE imaging of the distal ascending aorta and arch related to the extent of atherosclerosis. #safety #TEE

[A-View @stroke2prevent]

On May 20, CEO Dr. A. P. Nierich and CMO Dr. G. J. Brandon Bravo Bruinsma had the pleasure of visiting A-View distributor DeRoyal's headquarters in Knoxville, Tennessee, USA.

#DeRoyal #Knoxville #Stroke2Prevent #A-View #CEO #CMO @deroyal

[A-View @stroke2prevent]

On January 24th, 2022, the A-View cardiac safety device was launched for the US market by the CEO of Stroke2Prevent dr. Arno P. Nierich (l) and Cardiac Surgeon dr. George J. Brandon Bravo Bruinsma (r), during the National Sales Meeting of DeRoyal Industries Inc. in San Antonio.

[DeRoyal Industries, Inc. @deroyal]

NEW PRODUCT! The #A-View® #Endotracheal Balloon #Catheter can assist in obtaining the best #vascular views during #cardiac procedures. See the A-View Vascular TEE GUIDE & Instructions for Use: https://t.co/6OYyjRPl9B

[A-View @stroke2prevent]

We are proud to launch our renewed website. Visit: https://t.co/v2yp0nHB0y

#A-View #Website #stroke2prevent

[Isala @IsalaZiekenhuis]

Sterftedaling na hartoperaties door datadeling hartcentra https://t.co/2MfzbY1ZR0 via @Zorgvisie GOED NIEUWS: sterftedaling na hartoperaties ook dankzij #safetycheck #Isala #hartcentrum

[A-View @stroke2prevent]

A-View of @stroke2prevent obtained Australian TGA approval. This was realized in collaboration with Advanced Biomedical Pty Ltd, the exclusive distribution partner for Australia. #AView #TGAgovau

[A-View @stroke2prevent]

Last day #EACTS2017. Come and visit us at booth 30 to know more about our new clinics evidence.

[A-View @stroke2prevent]

Nearly ready for #EACTS2017.... exhibition opens tomorrow at 15:00. See you at booth No. 30.

[A-View @stroke2prevent]

A few days before the @EACTS starts. We are looking forward meeting you at booth 30 to inform you about our new clinical evidence.

[Jolanda van Duinen @J_vanDuinen]

Proud to be part of the @HealthHolland delegation at @MedTechCon in San Jose.
We can be recognized by our orange lanyards.

[A-View @stroke2prevent]

#Aview of @stroke2prevent will be shown during @MedTechCon at booth 1026 @healthholland. Opening tomorrow!

[A-View @stroke2prevent]

Impact of modified #TEE: study demonstrated 30% mortality reduction in #cardiacsurgery (#AView)
https://t.co/jrMbHhocKA

[A-View @stroke2prevent]

Stroke2prevent Receives FDA 510(k) Clearance for A-View https://t.co/swOWWvrB7x

[Endovascular Today @EVToday]

FDA Clears Stroke2prevent's A-View Balloon Catheter for TEE
https://t.co/t3SC1vqiJy

[A-View @stroke2prevent]

Our new website is available. Take a look at https://t.co/v2yp0nHB0y
#aview #echocardiography #modifiedTEE #medicaldevice

[A-View @stroke2prevent]

Global media coverage of FDA clearance #AView in cardiac market.
https://t.co/kgKDPlJBBV

[Jolanda van Duinen @J_vanDuinen]

US FDA clears Stroke2prevent’s A-View balloon catheter https://t.co/s2DyMj4TIz via @vascularnews

[A-View @stroke2prevent]

A-View nu ook in de VS - Reporters Online https://t.co/a5wp0OEXsy

[Zoltan Laszlo @zoltan_laszlo]

#PPMOost: Stroke2prevent ontvangt Amerikaanse FDA-goedkeuring voor A-View®: A-View ballonkatheter, is een uniek… https://t.co/VlIH5YdL8T